Extramedullary plasmacytomas following successful radiotherapy of Hodgkin's disease. Clinical and immunologic aspects.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001536:Bence Jones Protein / Q000096:biosynthesis*; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D006801:Humans; D007072:Immunoglobulin D / Q000096:biosynthesis; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D010950:Plasma Cells / Q000378:metabolism; D010954:Plasmacytoma / Q000097:blood / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D011878:Radiotherapy / Q000009:adverse effects; D012878:Skin Neoplasms / Q000209:etiology*; D013736:Testicular Neoplasms / Q000209:etiology*
D000970:Antineoplastic Agents; D007072:Immunoglobulin D; D001536:Bence Jones Protein; D008558:Melphalan